Likelihood of Positive Urine Screens of THC-COOH after Daily Use of Full-Spectrum Hemp Extracts Varies as a Function of Screening Criterion Used

Morgan L. Ferretti; Ryan Vandrey; Jessica G. Irons; Heather Jackson; Mallory J. Loflin; Travis Hyke; Marcel O. Bonn-Miller

doi:10.1097/FTD.0000000000001032

Likelihood of Positive Urine Screens of THC-COOH after Daily Use of Full-Spectrum Hemp Extracts Varies as a Function of Screening Criterion Used

Morgan L. Ferretti, Ryan Vandrey, Jessica G. Irons, Heather Jackson, Mallory J. Loflin, Travis Hyke, Marcel O. Bonn-Miller

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	126-127
Number of pages	2
Journal	Therapeutic drug monitoring
Volume	45
Issue number	1
DOIs	https://doi.org/10.1097/FTD.0000000000001032
State	Published - Feb 1 2023

ASJC Scopus subject areas

Pharmacology (medical)
Pharmacology

Access to Document

10.1097/FTD.0000000000001032

Cite this

@article{9f37f314b7024032b737644d13489bea,

title = "Likelihood of Positive Urine Screens of THC-COOH after Daily Use of Full-Spectrum Hemp Extracts Varies as a Function of Screening Criterion Used",

author = "Ferretti, {Morgan L.} and Ryan Vandrey and Irons, {Jessica G.} and Heather Jackson and Loflin, {Mallory J.} and Travis Hyke and Bonn-Miller, {Marcel O.}",

note = "Funding Information: Supported by a grant from the Institute for Research on Cannabinoids (IROC), a 501(c) (3) nonprofit organization supported by individual donations. Funding Information: The authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest: M.L. Ferretti reports personal fees from the Canopy Growth Corporation outside of the submitted work. R. Vandrey reports personal fees from Canopy Growth Corporation, personal fees from MyMD Pharmaceuticals, personal fees from Mira1a Therapeutics, personal fees from Radicle Science Inc, and personal fees from Syqe Medical Ltd, outside the submitted work. J.G. Irons reports a grant and non-financial support from the Canopy Growth Corporation outside the submitted work. M.J. Loflin reports personal fees and nonfinancial support from Jazz Pharmaceuticals. M.O. Bonn-Miller reports personal fees and non-financial support from Canopy Growth Corporation, personal fees and nonfinancial support from AusCann Group Ltd., personal fees and nonfinancial support from the Realm of Caring Foundation, and personal fees and non-financial support from The Lambert Center for the Study of Medicinal Cannabis and Hemp, outside the submitted work. ",

year = "2023",

month = feb,

day = "1",

doi = "10.1097/FTD.0000000000001032",

language = "English (US)",

volume = "45",

pages = "126--127",

journal = "Therapeutic drug monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Likelihood of Positive Urine Screens of THC-COOH after Daily Use of Full-Spectrum Hemp Extracts Varies as a Function of Screening Criterion Used

AU - Ferretti, Morgan L.

AU - Vandrey, Ryan

AU - Irons, Jessica G.

AU - Jackson, Heather

AU - Loflin, Mallory J.

AU - Hyke, Travis

AU - Bonn-Miller, Marcel O.

N1 - Funding Information: Supported by a grant from the Institute for Research on Cannabinoids (IROC), a 501(c) (3) nonprofit organization supported by individual donations. Funding Information: The authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest: M.L. Ferretti reports personal fees from the Canopy Growth Corporation outside of the submitted work. R. Vandrey reports personal fees from Canopy Growth Corporation, personal fees from MyMD Pharmaceuticals, personal fees from Mira1a Therapeutics, personal fees from Radicle Science Inc, and personal fees from Syqe Medical Ltd, outside the submitted work. J.G. Irons reports a grant and non-financial support from the Canopy Growth Corporation outside the submitted work. M.J. Loflin reports personal fees and nonfinancial support from Jazz Pharmaceuticals. M.O. Bonn-Miller reports personal fees and non-financial support from Canopy Growth Corporation, personal fees and nonfinancial support from AusCann Group Ltd., personal fees and nonfinancial support from the Realm of Caring Foundation, and personal fees and non-financial support from The Lambert Center for the Study of Medicinal Cannabis and Hemp, outside the submitted work.

PY - 2023/2/1

Y1 - 2023/2/1

UR - http://www.scopus.com/inward/record.url?scp=85145976116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85145976116&partnerID=8YFLogxK

U2 - 10.1097/FTD.0000000000001032

DO - 10.1097/FTD.0000000000001032

M3 - Letter

C2 - 36191288

AN - SCOPUS:85145976116

SN - 0163-4356

VL - 45

SP - 126

EP - 127

JO - Therapeutic drug monitoring

JF - Therapeutic drug monitoring

IS - 1

ER -

Likelihood of Positive Urine Screens of THC-COOH after Daily Use of Full-Spectrum Hemp Extracts Varies as a Function of Screening Criterion Used

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this